Respiratory Updates
🟢 To stay up-to-date on pharmacotherapy and other aspects of respiratory diseases🫁 🟢 Thoracic Research Center🔬 🟢 Tehran University of Medical Sciences🎓
Show more📈 Analytical overview of Telegram channel Respiratory Updates
Channel Respiratory Updates (@respiratoryupdates) in the English language segment is an active participant. Currently, the community unites 19 484 subscribers, ranking 1 176 in the Medicine category and 17 179 in the Iran region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 19 484 subscribers.
According to the latest data from 30 August, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 484 over the last 30 days and by 8 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 12.30%. Within the first 24 hours after publication, content typically collects 5.50% reactions from the total number of subscribers.
- Post reach: On average, each post receives 2 394 views. Within the first day, a publication typically gains 1 070 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 6.
- Thematic interests: Content is focused on key topics such as patient, guideline, edit, reader, society.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“🟢 To stay up-to-date on pharmacotherapy and other aspects of respiratory diseases🫁
🟢 Thoracic Research Center🔬
🟢 Tehran University of Medical Sciences🎓”
Thanks to the high frequency of updates (latest data received on 31 August, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
Data loading in progress...
| Date | Subscriber Growth | Mentions | Channels | |
| 31 August | +17 | |||
| 30 August | +8 | |||
| 29 August | +20 | |||
| 28 August | +25 | |||
| 27 August | +13 | |||
| 26 August | +14 | |||
| 25 August | +12 | |||
| 24 August | +19 | |||
| 23 August | +15 | |||
| 22 August | +13 | |||
| 21 August | +16 | |||
| 20 August | +22 | |||
| 19 August | +17 | |||
| 18 August | +12 | |||
| 17 August | +19 | |||
| 16 August | +17 | |||
| 15 August | +21 | |||
| 14 August | +15 | |||
| 13 August | +12 | |||
| 12 August | +25 | |||
| 11 August | +34 | |||
| 10 August | +10 | |||
| 09 August | +14 | |||
| 08 August | +5 | |||
| 07 August | +14 | |||
| 06 August | +14 | |||
| 05 August | +17 | |||
| 04 August | +18 | |||
| 03 August | +17 | |||
| 02 August | +18 | |||
| 01 August | +12 |
| 2 | IDSA_Treatment_of_Antimicrobial_Resistant_Gram_Negative_Infections.pdf | 2 450 |
| 3 | SARCOIDOSIS: Edited by Vasileios Kouranos and Maneesh Bhargava
Recent updates in advanced pulmonary sarcoidosis
Current Opinion in Pulmonary Medicine 32(5):p 491-499, September 2026. | DOI: 10.1097/MCP.0000000000001295 | 4 995 |
| 4 | Respiratory Medicine
Volume 255, April–May 2026, 108751
Original Research
The effect of the CareAide® mobile application in adult outpatients with asthma: A randomised controlled trial
https://doi.org/10.1016/j.rmed.2026.108751 | 4 388 |
| 5 | Navigating evidence-based recommendations for the management of systemic sclerosis. Nat Rev Rheumatol (2026). https://doi.org/10.1038/s41584-026-01416-z | 4 453 |
| 6 | Review Article
Nebulized Heparin in Adults With Acute Respiratory Failure: A Meta-Analysis of Randomized Trials
the Nebulized Heparin Study Group
Critical Care Medicine 54(7):p 1755-1766, July 2026. | DOI: 10.1097/CCM.0000000000007161 | 4 661 |
| 7 | Annals of intensive care.pdf | 4 784 |
| 8 | American Journal of Kidney Diseases
Available online 3 July 2026
In Press, Journal Pre-proof
Perspective
Approach to Hyperkalemia: The Role of Diet and Pharmacological Therapies
https://doi.org/10.1053/j.ajkd.2026.03.048 | 4 833 |
| 9 | ICU Nutrition Q&A.pdf | 4 837 |
| 10 | خلاصه وازوپرسو و اینوتروپ
#Critical_Care | 5 050 |
| 11 | آقای ۶۲ ساله با تشخیص شوک سپتیک ناشی از پنومونی، در icu . بیمار تحت رژیم درمانی با نوراپینفرین ۳۶ میکروگرم در دقیقه قرار دارد.
در آخرین بررسی:
· MAP = ۵۵ U/O = ۰.۳ cc/kh/ht · لاکتات سرم = ۴.۲ (روند نزولی ندارد) · CRT = ۴ بهترین اقدام؟ | 1 |
| 12 | Feature Article
Inhaled Antibiotics to Treat Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis
Critical Care Medicine 54(6):p 1293-1308, June 2026. | DOI: 10.1097/CCM.0000000000007072 | 5 705 |
| 13 | +2 The Lancet Respiratory Medicine
Available online 5 June 2026
In Press, Corrected Proof
Position Paper
Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment—an expert group consensus statement
https://doi.org/10.1016/S2213-2600(26)00094-9 | 6 903 |
| 14 | Critical_Care_2025 مبادرة خير.pdf | 6 369 |
| 15 | No text... | 3 364 |
| 16 | No text... | 3 330 |
| 17 | The new ACC/AHA 2026 guidelines of pulmonary embolism | 3 276 |
| 18 | creager_et_al_2026_2026_aha_acc_accp_acep_chest_sc_260219_225656.pdf | 4 146 |
| 19 | No text... | 5 051 |
| 20 | The Lancet Respiratory Medicine
Available online 12 February 2026
In Press, Corrected Proof
Articles
Budesonide–glycopyrronium–formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trials
KALOS and LOGOS study investigators †
https://doi.org/10.1016/S2213-2600(25)00457-6 | 5 027 |
